Children’s Tumor Foundation shared a post on LinkedIn:
“We’re excited to welcome John Puziss, PhD as the new Chief Scientific and Impact Officer at the Children’s Tumor Foundation.
John will lead CTF’s Science team and research portfolio, guiding strategic investments and partnerships to help accelerate the development of therapies for people living with NF.
With more than two decades of leadership experience, most recently as Deputy Director of Technology Transfer at Dartmouth College, John brings a proven track record of advancing promising science toward real-world impact.
This appointment reflects CTF’s laser-focused commitment to getting more approved therapies to NF patients faster. The CSIO role is designed for this moment — to accelerate the next wave of transformative therapies by making targeted investments in the most promising science, removing barriers that slow progress, and building the partnerships needed to move treatments to patients faster.
Click here to read more about John’s appointment.”
More posts about Children’s Tumor Foundation.